VPRIV subst sèche 400 U flac
7680612970026
CH-61297
A16AB10
07.14.0.
Reimbursement limitations:
VPRIV
Pour le traitement enzymatique substitutif au long cours de patients ayant de la maladie de …
1 / 3
google
Details
- Product number
- 6129702
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: velaglucerasum alfa 400 U., saccharum, natrii citras dihydricus corresp. natrium 12.15 mg, acidum citricum monohydricum, polysorbatum 20, pro vitro.
Articles (1)
VPRIV 400 U, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
400.0 U | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
12.15 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2145.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2010
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61297
- Drug name
- VPRIV, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- A16AB10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/08/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VPRIV subst sèche 400 U flac
- Description (DE)
- VPRIV Trockensub 400 E Durchstf
- Market launch
- 29/08/2011
- Narcotic (BTM)
- No